Akorn Recalls Hydrocortisone Otic Solution Due to Missing Safety Seal
Akorn, Inc. is recalling 13,896 bottles of Hydrocortisone and Acetic Acid Otic Solution because the bottles are missing the safety seal around the neck.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The issue is a packaging defect (missing seal) rather than a direct contamination or chemical hazard.
Plain-English summary
Akorn, Inc. is recalling 13,896 bottles of Hydrocortisone and Acetic Acid Otic Solution, USP. The affected product is a prescription-only medication containing hydrocortisone (1%) and acetic acid (2%) in 10 mL bottles. The specific lot number is 346191, with an expiration date of 12/2016. The product was distributed nationwide and in Puerto Rico.
The recall was initiated because the bottles are missing the safety seal around the neck. The product label explicitly states, "Tamper Evident: Do not use if printed seal around cap is broken or missing." Because the product is missing this approved component and is not consistent with its labeling, the lot is being recalled.
Consumers and healthcare providers should check their inventory for this specific lot and stop using the product if the safety seal is missing. The FDA has classified this recall as Class III, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences.
The recalled product
- Product
- Hydrocortisone and Acetic Acid Otic Solution, USP, containing hydrocortisone (1%) and acetic acid (2%), 10 mL bottles, Rx Only, Hi-Tech Pharmacal, Amityville, NY 11701, Made in USA, NDC # 50383-901-10
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Ophthalmic/ENT
- Affected units
- 13,896
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 346191
- Exp. 12/2016
Distribution
Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · packaging defect
See all →- HighEmbosphere Microspheres Recalled Due to Packaging Sterility Concerns
FDA (Devices) · 2026-10-07
- ModerateAmneal Recalls Estradiol Gel Packets Due to Empty or Partially Full Containers
FDA (Drugs) · 2026-10-07
- HighCardinal Health Recalls Presource Convenience Kits Due to Seal Defects
FDA (Devices) · 2026-09-30
- ModerateAVID Medical Recalls Halyard IV Start Kits Due to Packaging Seal Issues
FDA (Devices) · 2026-09-30
- HighCardinal Health Recalls Presource Convenience Kits Due to Potential Seal Defects
FDA (Devices) · 2026-09-30
Similar recalls
- SevereAkorn Recalls Subpotent Hydrocortisone and Acetic Acid Otic Solution
FDA (Drugs) · 2020-02-19
- ModerateAkorn Recalls Hydrocortisone and Acetic Acid Otic Solution Due to Low Potency
FDA (Drugs) · 2019-03-27
- HighHydrocortisone and Acetic Acid Otic Solution Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2023-06-07
- ModerateOxycodone Hydrochloride Oral Solution recalled for missing label
FDA (Drugs) · 2022-01-19
- LowActavis Recalls Hydrocortisone and Acetic Acid Otic Solution Due to Impurities
FDA (Drugs) · 2016-08-31
- LowAkorn Recalls Atropine Sulfate Ophthalmic Solution Due to Viscosity Failure
FDA (Drugs) · 2018-03-14